3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium chloride hydrate (1:1:2)(CAS: 273724-21-3)

This compound requires adherence to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for safety classification and labeling. Under the European Union, it is subject to the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. For products in the United States, the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) may also have specific requirements related to its use and handling.

Synthetic alternatives might include similar thiazole derivatives with different functional groups or analogs with alternative substituents. Common alternatives in synthesis include using different amino or phosphonate compounds, which can provide similar biological activities or properties in various applications.

The market for this compound is currently driven by its applications in pharmaceuticals and biotechnology. Research trends indicate a focus on its potential as a drug candidate for treating various diseases, particularly those involving pyrimidine derivatives. There is also increasing interest in its use in developing new therapeutic agents and improving existing treatments.

Waste containing this compound should be collected in appropriate containers and handled according to local regulations. Proper disposal methods may include incineration or professional waste disposal services. Environmental protection measures should be taken to prevent contamination of soil and water. It is advisable to consult with local environmental authorities for specific disposal guidelines.